MDOC™ and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis

Life Sciences

Volumn 78, Issue 17, 2006, Pages 1983-1989

  Nachtigal, Petr ^a   Pospisilova, Nada ^a   Pospechova, Katerina ^a   Jamborova, Gabriela ^a   Kopecky, Martin ^a   Jaynes, Robert ^a   Briestensky, Jiri ^c   Santar, Ivan ^c   Smahelova, Alena ^b   Solichova, Dagmar ^b   Zdansky, Petr ^b   Semecky, Vladimir ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^c Alltracel Laboratories Ltd   (Czech Republic)

Author keywords

Atherosclerosis; Atorvastatin; Cell adhesion molecules; MDOC ; Mice; Simvastatin

Indexed keywords

APOLIPOPROTEIN E; ATORVASTATIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN; MDOC; OXIDIZED CELLULOSE; SIMVASTATIN; VASCULAR CELL ADHESION MOLECULE 1; VERY LOW DENSITY LIPOPROTEIN; ANTIINFLAMMATORY AGENT; HEPTANOIC ACID DERIVATIVE; LIPOPROTEIN; PYRROLE DERIVATIVE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET THERAPY; HYPERLIPIDEMIA; HYPOLIPEMIA; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STEREOLOGY; VASCULAR ENDOTHELIUM; ANIMAL; BLOOD; DIET; DISEASE MODEL; DRUG EFFECT; GENETICS; METABOLISM; MOUSE MUTANT; ORAL DRUG ADMINISTRATION; PATHOLOGY;

ANIMALIA;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELLULOSE, OXIDIZED; DIET; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HEPTANOIC ACIDS; HYPERLIPIDEMIAS; INTERCELLULAR ADHESION MOLECULE-1; LIPOPROTEINS; MALE; MICE; MICE, KNOCKOUT; PYRROLES; SIMVASTATIN; TRIGLYCERIDES; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33644627717     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.08.041     Document Type: Article

References (36)

1. M. Ahmed, and P. Griffiths Statins and secondary prevention of coronary heart disease British Journal of Community Nursing 9 2004 160 165
2. M. Aikawa, S. Sugiyama, C.C. Hill, S.J. Voglic, E. Rabkin, Y. Fukumoto, F.J. Schoen, J.L. Witztum, and P. Libby Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma Circulation 106 2002 1390 1396
3. F. Bea, E. Blessing, B. Bennett, M. Levitz, E.P. Wallace, and M.E. Rosenfeld Simvastatin promotes atherosclerotic plaque stability in apoE-deficient mice independently of lipid lowering Arteriosclerosis Thrombosis and Vascular Biology 22 2002 1832 1837
4. T.P. Carr, D.D. Gallaher, C.H. Yang, and C.A. Hassel Increased intestinal contents viscosity reduces cholesterol absorption efficiency in hamsters fed hydroxypropyl methylcellulose Journal of Nutrition 126 1996 1463 1469
5. M.J. Davies, N. Woolf, P.M. Rowles, and J. Pepper Morphology of the endothelium over atherosclerotic plaques in human coronary arteries British Heart Journal 60 1988 459 464
6. T.J. DeGraba Expression of inflammatory mediators and adhesion molecules in human atherosclerotic plaque Neurology 49 1997 S15 S19
7. J.A. Farmer Pleiotropic effects of statins Current Atherosclerosis Reports 2 2000 208 217
8. H.J. Gundersen, P. Bagger, T.F. Bendtsen, S.M. Evans, L. Korbo, N. Marcussen, A. Moller, K. Nielsen, J.R. Nyengaard, and B. Pakkenberg The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis Apmis 96 1988 857 881
9. K. Iiyama, L. Hajra, M. Iiyama, H. Li, M. DiChiara, B.D. Medoff, and M.I. Cybulsky Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation Circulation Research 85 1999 199 207
10. M. Jelinkova, J. Briestensky, I. Santar, and B. Rihova In vitro and in vivo immunomodulatory effects of microdispersed oxidized cellulose International Immunopharmacology 2 2002 1429 1441
11. J.C. LaRosa Pleiotropic effects of statins and their clinical significance American Journal of Cardiology 88 2001 291 293
12. U. Laufs, V. La Fata, J. Plutzky, and J.K. Liao Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 1998 1129 1135
13. M.A. Levrat-Verny, S. Behr, V. Mustad, C. Remesy, and C. Demigne Low levels of viscous hydrocolloids lower plasma cholesterol in rats primarily by impairing cholesterol absorption Journal of Nutrition 130 2000 243 248
14. K. Ley, and Y. Huo VCAM-1 is critical in atherosclerosis Journal of Clinical Investigation 107 2001 1209 1210
15. W. Li, T. Asagami, H. Matsushita, K.H. Lee, and P.S. Tsao Rosuvastatin attenuates monocyte-endothelial cell interactions and vascular free radical production in hypercholesterolemic mice Journal of Pharmacology and Experimental Therapeutics 313 2005 557 562
16. K.C. Maki, M.H. Davidson, S. Torri, K.A. Ingram, J. O'Mullane, B.P. Daggy, and H.H. Albrecht High-molecular-weight hydroxypropylmethylcellulose taken with or between meals has hypocholesterolemic effects in adult men Journal of Nutrition 130 2000 1705 1710
17. P. Nachtigal, V. Semecky, A. Gojova, M. Kopecky, V. Benes, and R. Juzkova The application of stereological methods for the quantitative analysis of the atherosclerotic lesions in rabbits Image Analysis and Stereology 21 2002 165 174
18. P. Nachtigal, V. Semecky, M. Kopecky, A. Gojova, D. Solichova, P. Zdansky, and Z. Zadak Application of stereological methods for the quantification of VCAM-1 and ICAM-1 expression in early stages of rabbit atherogenesis Pathology Research and Practice 200 2004 219 229
19. Y. Nakashima, A.S. Plump, E.W. Raines, J.L. Breslow, and R. Ross ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree Arteriosclerosis and Thrombosis 14 1994 133 140
20. Y. Nakashima, E.W. Raines, A.S. Plump, J.L. Breslow, and R. Ross Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoEdeficient mouse Arteriosclerosis Thrombosis and Vascular Biology 18 1998 842 851
21. M. Ortego, C. Bustos, M.A. Hernandez-Presa, J. Tunon, C. Diaz, G. Hernandez, and J. Egido Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells Atherosclerosis 147 1999 253 261
22. R.L. Reddick, S.H. Zhang, and N. Maeda Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression Arteriosclerosis and Thrombosis 14 1994 141 147
23. M. Richardson, S.J. Hadcock, M. DeReske, and M.I. Cybulsky Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits Arteriosclerosis and Thrombosis 14 1994 760 769
24. R. Ross Atherosclerosis-an inflammatory disease New England Journal of Medicine 340 1999 115 126
25. J. Rysava, L. Masova, J.E. Dyr, J. Suttnar, P. Salaj, J. Dostalek, K. Myska, and M. Pecka Effect of oxidized cellulose on fibrin formation and blood platelets Casopis Lekaru Ceskych 141 2002 50 53 (Suppl)
26. U. Schonbeck, and P. Libby Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? Circulation 109 2004 II18 II26
27. M. Sierra, J.J. Garcia, N. Fernandez, M.J. Diez, and A.P. Calle Therapeutic effects of psyllium in type 2 diabetic patients European Journal of Clinical Nutrition 56 2002 830 842
28. C.P. Sparrow, C.A. Burton, M. Hernandez, S. Mundt, H. Hassing, S. Patel, R. Rosa, A. Hermanowski-Vosatka, P.R. Wang, D. Zhang, L. Peterson, P.A. Detmers, Y.S. Chao, and S.D. Wright Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering Arteriosclerosis Thrombosis and Vascular Biology 21 2001 115 121
29. T.A. Springer Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm Cell 76 1994 301 314
30. T.A. Springer Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration Annual Review of Physiology 57 1995 827 872
31. G.K. Sukhova, J.K. Williams, and P. Libby Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol Arteriosclerosis Thrombosis and Vascular Biology 22 2002 1452 1458
32. C.J. Vaughan, M.B. Murphy, and B.M. Buckley Statins do more than just lower cholesterol Lancet 348 1996 1079 1082
33. Y.X. Wang, B. Martin-McNulty, L.Y. Huw, V. da Cunha, J. Post, J. Hinchman, R. Vergona, M.E. Sullivan, W. Dole, and K. Kauser Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E Atherosclerosis 162 2002 23 31
34. H. Watanabe, K. Kosuge, S. Nishio, H. Yamada, S. Uchida, H. Satoh, H. Hayashi, T. Ishizaki, and K. Ohashi Pharmacokinetic and pharmacodynamic interactions between simvastatin and diltiazem in patients with hypercholesterolemia and hypertension Life Sciences 76 2004 281 292
35. E. Weibel Stereological methods Practical Methods for Biology Morphometry vol. 1 1979 Academic Press
36. S.H. Zhang, R.L. Reddick, J.A. Piedrahita, and N. Maeda Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E Science 258 1992 468 471